Meissner, K. “Hemorrhage Caused by Ruptured Liver Cell Adenoma Following Long-Term Oral Contraceptives: A Case Report”. Hepatogastroenterology 45, no. 19 (1998): 224–25. Mueck, A. O., et al. “Estradiol Metabolism and Malignant Disease”. Maturitas 43, no. 1 (2002): 1–10.

Muti, P., et al. “Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16Alpha-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women”. Epidemiology 11, no. 6 (2000): 635–40.

Nime, F., et al. “The Histology of Liver Tumors in Oral Contraceptive Users Observed During a National Survey by the American College of Surgeons Commission on Cancer”. Cancer 44, no. 4 (1979): 1481–89.

Nwachukwu, J. C., et al. “Resveratrol Modulates the Inflammatory Response Via an Estrogen Receptor-Signal Integration Network”. Elife 3 (2014): e02057.

Oredipe, O. A., et al. “Dietary Glucarate-Mediated Inhibition of Initiation of Diethyl-nitrosamine-Induced Hepatocarcinogenesis”. Toxicology 74, nos. 2–3 (1992): 209–22.

Panzer, C., et al. “Impact of Oral Contraceptives on Sex Hormone – Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction”. Journal of Sexual Medicine 3, no. 1: 104–13.

Prigge, J. R., et al. “Hepatocyte DNA Replication in Growing Liver Requires Either Glutathione or a Single Allele of TXNRD1”. Free Radical Biology and Medicine 52, no. 4 (2012): 803–10.

Racine, A., et al. “Menopausal Hormone Therapy and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort”. Canadian Medical Association Journal 185, no. 7 (2013): 555–61.

Rafogianis, R., et al. “Estrogen Metabolism by Conjugation”. Journal of the National Cancer Institute Monographs 27 (2000): 113–24.

Rooks, J. B., et al. “Epidemiology of Hepatocellular Adenoma. The Role of Oral Contraceptive Use”. JAMA 242, no. 7 (1979): 644–48.

Rosenberg, L. “The Risk of Liver Neoplasia in Relation to Combined Oral Contraceptive Use”. Contraception 43, no. 6 (1991): 643–52.

Ruotolo, R., et al. “Anti-Estrogenic Activity of a Human Resveratrol Metabolite”. Nutrition, Metabolism, and Cardiovascular Diseases 23, no. 11 (2013): 1086–92.

Schuurman, H. J., et al. “Chemicals Trophic for the Thymus: Risk for Immunodeficiency and Autoimmunity”. International Journal of Immunopharmacology 14, no. 3 (1992): 369–75.

Shortell, C. K., et al. “Hepatic Adenoma and Focal Nodular Hyperplasia”. Surgery, Gynecology, and Obstetrics 173, no. 5 (1991): 426–31.

Søe, K. L., et al. “Liver Pathology Associated with the Use of Anabolic-Androgenic Steroids”. Liver 12, no. 2 (1992): 73–79.